GRT US Holding, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$16.3M
Doctors Paid
10,200
Transactions
28,935
2024 Total
$39,958
Payment Breakdown by Category
Research$12.0M (73.8%)
Consulting$1.4M (8.5%)
Travel$811,441 (5.0%)
Food & Beverage$662,114 (4.1%)
Royalty/License$13,888 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12.0M | 2,206 | 73.8% |
| Consulting Fee | $1.4M | 253 | 8.5% |
| Honoraria | $1.2M | 488 | 7.2% |
| Travel and Lodging | $811,441 | 1,645 | 5.0% |
| Food and Beverage | $662,114 | 24,224 | 4.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208,629 | 77 | 1.3% |
| Royalty or License | $13,888 | 6 | 0.1% |
| Grant | $3,000 | 1 | 0.0% |
| Education | $1,525 | 35 | 0.0% |
Payments by Type
Research
$12.0M
2,206 transactions
General
$4.3M
26,729 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE INTRAARTICULAR INJECTION OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $6.3M | 0 | 1,323 |
| KF7013-04 | $1.6M | 3 | 295 |
| KF7013-02 | $1.4M | 5 | 348 |
| PSNP | $1.1M | 0 | 4 |
| PSMP | $636,282 | 0 | 2 |
| AV001 | $430,482 | 0 | 169 |
| A SINGLEARM OPENLABEL PHASE III TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN SUBJECTS WITH MODERATE TO SEVERE PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $350,568 | 0 | 42 |
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $175,533 | 0 | 20 |
| Surgery Registry Study | $7,591 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Dr. Shravani Durbhakula, M.d, M.D | Anesthesiology | Nashville, TN | $343,749 | $0 |
| Alexander Ford, Md, MD | Cardiovascular Disease | Los Angeles, CA | $257,402 | $0 |
| Alaa Abd-Elsayed | Pain Medicine | Madison, WI | $251,974 | $0 |
| Dr. Mark Coleman, Md, MD | Interventional Pain Medicine | Pikesville, MD | $201,384 | $0 |
| Dr. David Simpson, M.d, M.D | Neurology | New York, NY | $160,290 | $0 |
| Dr. David Reece, D.o, D.O | Pain Medicine | Bethesda, MD | $138,802 | $0 |
| Dr. Adam Teichman, Dpm, DPM | Foot & Ankle Surgery | Allentown, PA | $131,894 | $0 |
| James North, Md, MD | Pain Medicine | Winston Salem, NC | $99,669 | $0 |
| Stephanie Simon, Aprn, APRN | Family | Omaha, NE | $99,299 | $0 |
| Dr. Mark Borchelt, Md, Face, MD, FACE | Endocrinology, Diabetes & Metabolism | Gulfport, MS | $86,517 | $0 |
| Mayank Gupta, Md (Mbbs), MD (MBBS) | Pain Medicine | Overland Park, KS | $82,294 | $0 |
| Zohra Hussaini, Arnp, ARNP | Family | Kansas City, KS | $67,875 | $0 |
| Dr. Yeshvant Navalgund, Md, MD | Pain Medicine | Greensburg, PA | $65,518 | $0 |
| Dr. Akilis Theoharidis, D.p.m, D.P.M | Podiatrist | Gladstone, MO | $61,766 | $0 |
| Nathaniel Schuster, M.d, M.D | Neurology | San Diego, CA | $58,749 | $0 |
| Paul Christo, M.d, M.D | Anesthesiology | Baltimore, MD | $55,220 | $0 |
| Dr. Justin Moon, M.d, M.p.h, M.D, M.P.H | Neurology | Denver, CO | $53,685 | $0 |
| Waleed El-Feky, M.d, M.D | Neurology | Dallas, TX | $53,271 | $0 |
| Charles Argoff, Md, MD | Neurology | Albany, NY | $51,700 | $0 |
| Steven Stanos, Do, DO | Physical Medicine & Rehabilitation | Seattle, WA | $50,546 | $0 |
| Dr. Anil Sharma, Md, MD | Psychiatry | Inglewood, CA | $50,190 | $0 |
| Dr. Naum Shaparin, M.d, M.D | Pain Medicine | Bronx, NY | $46,247 | $0 |
| Dr. Brian Costell, M.d, M.D | Neurology | Boca Raton, FL | $40,339 | $0 |
| Mr. Jeremy Adler, Pa-C, PA-C | Medical | San Diego, CA | $34,626 | $0 |
| Dr. Neel Mehta, Md, MD | Interventional Pain Medicine | New York, NY | $33,227 | $0 |
Ad
Top Products
- Qutenza $5.7M
- Neridronic acid $2.7M
Associated Products (4)
- Qutenza $5.7M
- Neridronic acid $2.7M
- Nerizonate $290,129
- Cutis $13,262
Payment Categories
- Food & Beverage $662,114
- Consulting $1.4M
- Travel & Lodging $811,441
- Research $12.0M
- Royalties $13,888
About GRT US Holding, Inc.
GRT US Holding, Inc. has made $16.3M in payments to 10,200 healthcare providers, recorded across 28,935 transactions in the CMS Open Payments database. In 2024, the company paid $39,958. The top product by payment volume is Qutenza ($5.7M).
Payments were distributed across 167 medical specialties. The top specialty by payment amount is Pain Medicine ($910,294 to 837 doctors).
Payment categories include: Food & Beverage ($662,114), Consulting ($1.4M), Research ($12.0M), Travel & Lodging ($811,441), Royalties ($13,888).
GRT US Holding, Inc. is associated with 4 products in the CMS Open Payments database, including Qutenza, Neridronic acid, and Nerizonate.